Myopia at Age 7
What to Expect and What to Do
Short answer: Myopia at age 7 is early-onset and requires active management from diagnosis. Children who become myopic at 7 have 11 years of growth ahead — during which untreated progression will compound significantly. IMI 2025 consensus: treat at diagnosis, not when progression becomes 'fast enough'.
Clinical picture: what this age means for myopia
Children with onset at age 7 are in the highest-risk group for reaching high myopia (≥−6D) by adulthood based on Tideman 2018 longitudinal data. The Sanz Diez 2019 meta-analysis showed that the younger the onset, the more total axial elongation occurs before natural stabilisation — making early treatment significantly more impactful per year than treatment started at 12 or 13.
What parents should do now
- Start myopia management at diagnosis — don't wait for faster progression
- Aim for 2 hours of outdoor time daily
- Every-6-month follow-up appointments are standard of care at this age
- Ask for axial length measurement at every visit
Treatment options at age 7
At age 7, Stellest® spectacle lenses or low-dose atropine are the primary options. Orthokeratology can be considered from around age 7–8. MiSight® from age 8.
See your child's projected prescription at age 18
Enter current age, axial length, and a prior measurement. Get projected adult prescription with and without treatment — in under 60 seconds.
Project myopia progression →How age at onset predicts lifetime risk
| Age myopia starts | Years of fast growth remaining | High myopia risk (without treatment) |
|---|---|---|
| Age 6 | ~12 years | Very high (est. 60–80%) |
| Age 7 | ~11 years | Very high (est. 55–75%) |
| Age 8 | ~10 years | High (est. 45–65%) |
| Age 9 | ~9 years | High (est. 35–55%) |
| Age 10 | ~8 years | Moderate–High (est. 25–45%) |
| Age 12 | ~6 years | Moderate (est. 15–30%) |
| Age 14 | ~4 years | Lower (est. 10–20%) |
| Age 16 | ~2 years | Low (est. 5–12%) |
High myopia defined as ≥−6.00D. Risk estimates based on Tideman 2018 longitudinal data; individual outcomes vary substantially. Your row is highlighted.
This page is for educational purposes and does not constitute medical advice. Diopter-to-axial-length conversions are approximations (±2–3D individual variation). MyopiaTracker is a decision-support tool — not a diagnostic device. Consult a qualified optometrist or ophthalmologist for personalised advice.